pubm
review
articl
mention
keyword
bronchiectasi
combin
epidemiolog
microbiolog
publish
perform
bronchiectasi
cystic
fibrosi
cf
repres
separ
diseas
entiti
right
retriev
articl
deal
exclus
cfassoci
bronchiectasi
exclud
origin
articl
without
radiolog
confirm
bronchiectasi
studi
adult
paediatr
popul
consid
appropri
includ
bronchiectasi
ageassoci
diseas
mark
increas
preval
particularli
sever
diseas
observ
elderli
global
shift
age
continu
influenc
burden
bronchiectasi
diseas
epidemiolog
implic
healthcar
system
provid
therapi
mani
chronic
lung
diseas
agerel
increas
preval
given
multifactori
impact
age
process
respiratori
physiolog
physiolog
chang
includ
decreas
diaphragm
strength
reduc
breath
effici
vital
capac
vc
coupl
increas
residu
volum
rv
import
influenc
diagnosi
interpret
pulmonari
function
test
pft
across
varieti
respiratori
patholog
describ
group
other
diminut
swallow
reflex
increas
preval
gord
elderli
may
contribut
develop
bronchiectasi
due
subclin
microaspir
includ
nasopharyng
microbiota
elderli
peopl
sever
diseas
atyp
present
poorer
outcom
compar
younger
cohort
ageassoci
diseas
manifest
also
correl
close
variat
immun
microbiom
signatur
associ
age
process
immun
system
potenti
microbiom
also
undergo
chang
age
process
incomplet
understood
term
immunosenesc
although
immunosenesc
influenc
varieti
respiratori
diseas
state
littl
known
effect
bronchiectasi
nevertheless
associ
lung
function
declin
infect
age
suggest
immunosenec
potenti
bronchiectasi
pathogenesi
like
interrel
immunosuppress
due
leukaemia
treatment
also
interestingli
associ
bronchiectasi
relev
observ
elderli
popul
ageassoci
pathway
includ
wnt
signal
mtor
tolllik
receptor
tlr
possibl
role
copd
ipf
pathogenesi
could
explain
ageassoci
sever
bronchiectasi
telomer
dysfunct
senesc
associ
pathway
describ
explant
studi
patient
bronchiectasi
repres
import
area
futur
interest
research
increas
risk
noncf
bronchiectasi
observ
extrem
age
children
year
adult
year
age
greatest
risk
diseas
particular
aetiolog
clinic
manifest
observ
childhood
bronchiectasi
frequent
includ
primari
secondari
immunodefici
ciliari
dyskinesia
congenit
malform
bronchiol
obliteran
skelet
diseas
adult
bronchiectasi
infect
highli
associ
diseas
childhood
bronchiectasi
increas
risk
sever
diseas
later
life
strike
incid
childhood
bronchiectasi
seen
indigen
popul
includ
maori
pacif
island
new
zealand
australian
aborigin
alaskan
nativ
children
increas
rate
also
observ
outsid
risk
popul
difficult
current
literatur
discern
broader
global
shift
bronchiectasi
preval
due
true
chang
understand
aetiolog
includ
childhood
altern
better
awar
diseas
develop
recent
time
cystic
fibrosi
cf
caus
dysfunct
absenc
cystic
fibrosi
transmembran
conductor
regul
protein
cftr
genet
predispos
affect
bronchiectasi
condit
preval
caucasian
popul
less
commonli
encount
asian
europ
north
america
australian
new
zealand
neonat
screen
wide
avail
peopl
cf
diagnos
soon
birth
major
noncf
bronchiectasi
studi
report
europ
australia
usa
identifi
aetiolog
label
idiopath
infect
crucial
pathophysiolog
bronchiectasi
unsurpris
postinfect
bronchiectasi
commonli
identifi
caus
diseas
develop
infect
mycobacterium
tuberculosi
nontuberculosi
mycobacteria
ntm
childhood
bordetella
pertussi
whoop
cough
virus
includ
influenza
measl
adenoviru
implic
postinfect
bronchiectasi
state
howev
mani
case
difficult
certain
aetiolog
recal
bia
event
often
mani
decad
past
importantli
copd
asthma
connect
tissu
diseas
immunodefici
note
import
potenti
contribut
factor
among
european
patient
gender
seem
addit
exert
effect
particular
aetiolog
male
like
exhibit
copd
femal
like
exhibit
asthmarel
aetiolog
european
patient
copd
also
tend
older
immunodefici
ciliari
dysfunct
irrit
bowel
diseas
ibd
observ
younger
patient
comorbid
seen
commonli
europ
includ
copd
asthma
ibd
repres
independ
mortal
risk
factor
noncf
bronchiectasi
copdassoci
bronchiectasi
lead
caus
europ
allerg
reaction
fungi
belong
genu
aspergillu
allerg
bronchopulmonari
aspergillosi
abpa
particularli
notabl
unit
kingdom
uk
base
cohort
bronchiectasi
caus
immunerel
mechan
includ
autoimmun
immunodefici
hematolog
malign
identifi
predomin
aetiolog
unit
state
work
demonstr
low
rate
idiopath
bronchiectasi
importantli
reveal
systemat
evalu
may
identifi
aetiolog
high
proport
case
suggest
earlier
uk
studi
us
immun
dysfunct
frequent
associ
bronchiectasi
includ
among
stemcel
transplant
recipi
suffer
graft
versu
host
diseas
outsid
indigen
canadian
cohort
high
rate
childhood
bronchiectasi
report
data
aetiolog
adult
canadian
noncf
bronchiectasi
rather
limit
precis
natur
aetiolog
countri
larg
uncertain
latin
america
aetiolog
like
elsewher
driven
infect
influenc
infecti
diseas
epidemiolog
endem
tb
region
backdrop
higher
rate
pertussi
measl
turn
relat
lower
vaccin
uptak
rate
higher
rate
pneumonia
tuberculosi
childhood
also
like
key
contribut
factor
bronchiectasi
region
true
preval
bronchiectasi
commun
asiapacif
region
larg
unknown
consid
potenti
diagnosi
popul
import
aetiolog
bronchiectasi
seen
region
includ
immunodefici
syndrom
common
variabl
immunodefici
secondari
immunoglobulin
disord
frequent
drug
relat
mucociliari
defect
includ
primari
ciliari
dyskinesia
chronic
aspir
autoimmuneconnect
tissu
diseas
particularli
rheumatoid
arthriti
abpa
describ
case
result
delay
diagnos
japan
less
studi
inflammatori
diseas
sinobronchi
syndrom
document
mani
case
bronchiectasi
geograph
variat
bronchiectasi
aetiolog
describ
select
referr
bias
extent
test
seek
diagnosi
bronchiectasi
individu
patient
may
result
observ
pattern
popul
report
figur
illustr
exist
literatur
avail
studi
focus
bronchiectasi
aetiolog
base
geographi
strike
variat
bronchiectasi
epidemiolog
observ
among
indigen
children
australia
alaska
canada
new
zealand
paediatr
popul
exhibit
except
high
rate
compar
nonindigen
group
infant
childhood
pneumonia
cite
primari
caus
mani
case
combin
observ
point
contribut
genet
predisposit
earli
childhood
infect
overal
lower
socioeconom
statu
import
featur
pathogenesi
particularli
among
specif
indigen
popul
consid
pacif
region
high
incid
observ
children
year
age
new
zealand
substanti
differ
note
within
indigen
ethnic
group
across
geograph
region
paediatr
bronchiectasi
new
zealand
idiopath
predomin
chronic
haemophilu
influenza
infect
turn
associ
reduc
lung
function
bronchiectasi
children
also
associ
high
rate
hospit
admiss
particularli
australian
aborigin
children
latter
group
one
highest
report
preval
rate
bronchiectasi
per
worldwid
separ
work
alaskan
nativ
children
describ
extrem
high
rate
bronchiectasi
compar
popul
individu
infant
childhood
pneumonia
primari
caus
diseas
aforement
patient
group
clearli
enrich
diseas
occurr
import
featur
offer
opportun
research
better
understand
role
interact
genet
predisposit
earli
childhood
infect
subsequ
develop
bronchiectasi
incid
preval
rate
bronchiectasi
uk
increas
annual
associ
signific
mortal
studi
uk
north
east
n
illustr
occurr
idiopath
bronchiectasi
high
identifi
postinfect
aetiolog
develop
condit
earlier
life
contrast
greek
studi
n
demonstr
prior
tuberculosi
pertussi
measl
pneumonia
lead
caus
bronchiectasi
retrospect
studi
nice
southern
franc
n
similarli
describ
high
rate
postinfecti
mainli
posttubercul
bronchiectasi
despit
countrybas
report
larg
multicentr
dataset
n
collat
across
europ
monza
itali
dunde
newcastl
uk
leuven
belgium
barcelona
spain
athen
greec
galway
ireland
illustr
patient
idiopath
diseas
among
identifi
caus
bronchiectasi
postinfecti
howev
remain
commonest
interestingli
larg
dataset
copdrel
bronchiectasi
associ
higher
bronchiectasi
sever
index
bsi
germani
preval
bronchiectasi
case
per
associ
concomit
increas
hospit
admiss
increas
incid
age
larg
popul
base
studi
catalonia
northeastern
spain
similarli
found
high
preval
case
per
incid
rate
case
per
contrast
global
dataset
preval
incid
bronchiectasi
studi
highest
older
male
larger
multicentr
studi
spain
howev
show
contrast
result
higher
preval
femal
elev
rate
postinfecti
diseas
interest
greater
hospit
admiss
treatment
cost
per
patient
spain
invers
relat
bronchiectasi
primari
diagnosi
increas
identifi
secondari
diagnosi
clearli
highlight
need
focu
earlier
diagnosi
northern
european
countri
finland
interestingli
report
lower
incid
bronchiectasi
compar
worldwid
estim
also
accompani
lower
hospitalis
mortal
rate
diseas
overal
data
clearli
illustr
chang
variat
epidemiolog
aetiolog
bronchiectasi
even
within
europ
turn
contrast
america
asian
subcontin
seitz
et
al
report
annual
increas
preval
bronchiectasi
us
higher
preval
asian
american
compar
european
african
american
base
thorac
comput
tomographi
ct
scan
similar
increas
bronchiectasi
incid
describ
high
rate
women
elderli
mcshane
et
al
illustr
ethnic
one
major
contribut
factor
observ
aetiolog
differ
diseas
import
consider
clinician
increasingli
multiethn
resid
popul
across
differ
countri
rheumatoid
arthriti
ra
interestingli
common
aetiolog
african
american
hematolog
malign
common
european
american
studi
subsequ
work
also
support
associ
hematolog
malign
bronchiectasi
role
connect
tissu
disord
also
corrobor
sever
investig
first
report
us
bronchiectasi
research
registri
recent
publish
characteris
patient
result
concur
other
illustr
higher
occurr
women
within
analys
cohort
higher
preval
diseas
describ
european
american
statu
bronchiectasi
larg
understudi
diseas
reflect
rel
lack
preval
data
canada
caribbean
south
america
studi
warrant
asian
subcontin
consider
gap
understand
bronchiectasi
epidemiolog
continu
exist
comprehens
preval
dataset
either
china
india
current
avail
howev
work
current
ongo
address
sporad
region
report
avail
provid
insight
bronchiectasi
highli
affect
region
recent
panindian
studi
n
identifi
postinfect
primari
caus
bronchiectasi
posttubercul
diseas
identifi
predomin
aetiolog
whilst
abpa
common
caus
identifi
indian
case
aetiolog
studi
across
differ
ethnic
guangzhou
region
mainland
china
n
identifi
idiopath
bronchiectasi
common
caus
high
rate
diseas
relat
postinfect
also
note
among
han
popul
mainland
china
n
rate
idiopath
bronchiectasi
even
strike
follow
posttuberculosi
preval
aetiolog
observ
chines
studi
illustr
whilst
posttubercul
bronchiectasi
remain
import
asia
idiopath
bronchiectasi
also
highli
preval
small
studi
hong
kong
n
idiopath
diseas
domin
patient
bronchiectasi
mainli
femal
high
hospitalis
mortal
rate
case
per
case
per
respect
contrast
china
howev
work
thailand
n
indic
postinfect
relat
bronchiectasi
specif
posttuberculosi
associ
diseas
commonest
similarli
high
preval
postinfecti
bronchiectasi
report
indian
children
n
follow
primari
ciliari
dyskinesia
abpa
high
preval
bronchiectasi
report
south
korea
n
one
particular
studi
respiratori
patient
deem
bronchiectasi
higher
preval
femal
varieti
reason
may
put
forward
explain
outlin
epidemiolog
differ
bronchiectasi
exist
across
europ
america
asiapacif
exampl
tuberculosi
rare
develop
countri
compar
asiapacif
africa
potenti
explain
high
frequenc
posttubercul
diseas
found
region
potenti
genet
predisposit
bronchiectasi
may
account
increas
diseas
preval
indigen
commun
asiapacif
region
influenc
environ
accompani
climat
may
also
influenc
microorgan
andor
pathogen
affect
bronchiectasi
airway
henc
next
outlin
geograph
variat
airway
microbiolog
bronchiectasi
may
account
observ
differ
epidemiolog
pattern
diseas
pseudomona
aeruginosa
h
influenza
common
bacteria
detect
bronchiectasi
airway
global
although
proport
vari
among
differ
popul
bacteri
genera
describ
bronchiectasi
airway
includ
streptococcu
prevotella
veillonella
staphylococcu
p
aeruginosa
associ
poorer
pulmonari
function
higher
hospitalis
rate
greater
morbid
mortal
compar
h
influenza
nontuberculosi
mycobacteria
ntm
anoth
import
group
organ
frequent
infect
airway
adult
bronchiectasi
bronchiectasi
ntm
highli
associ
pulmonari
diseas
airway
distort
predispos
ntm
infect
ntm
isol
bronchiectasi
airway
clearli
associ
poorer
outcom
aggress
diseas
case
larg
depend
speci
involv
studi
interestingli
associ
milder
phenotyp
less
sever
diseas
lower
exacerb
better
pulmonari
function
ntm
colonis
common
p
aeruginosa
frequent
older
patient
gender
preponder
postmenopaus
women
lower
preval
observ
paediatr
popul
mycobacterium
avium
complex
mac
gener
common
form
affect
bronchiectasi
patient
although
geograph
variat
exist
studi
children
focus
bronchiectasi
microbiolog
highlight
h
influenza
preval
sputum
organ
work
origin
new
zealand
note
p
aeruginosa
larg
consid
airway
organ
affect
adult
describ
children
bronchiectasi
pneumonia
catarrhali
also
describ
sever
studi
use
bronchoalveolar
lavag
bal
indigen
children
northern
australia
show
mark
similar
microbiolog
compar
new
zealand
dataset
except
none
children
latter
work
p
aeruginosa
posit
compar
european
paediatr
data
uk
ireland
children
found
similar
dichotomi
h
influenza
p
aeruginosa
airway
also
high
detect
pneumonia
howev
notabl
intracountri
differ
geograph
pattern
p
aeruginosa
low
level
newcastl
compar
higher
level
london
versu
respect
contrast
catarrhali
occurr
newcastl
higher
london
differ
may
reflect
differ
referr
pattern
presenc
specialist
clinic
particular
centr
nonetheless
serv
highlight
spectrum
diseas
heterogen
seen
children
evalu
data
adult
bronchiectasi
popul
uk
expectedli
higher
rate
p
aeruginosa
observ
compar
paediatr
cohort
taken
togeth
observ
suggest
variat
paediatr
bronchiectasi
microbiolog
may
complex
adult
illustr
withincountri
differ
addit
geograph
continent
variat
european
studi
bacteriom
adult
bronchiectasi
data
combin
spanish
scottish
dataset
illustr
equal
proport
h
influenza
p
aeruginosa
ecoli
interestingli
isol
tenth
studi
cohort
separ
work
greec
belgium
franc
concur
european
studi
detect
high
rate
airway
p
aeruginosa
h
influenza
low
ntm
import
studi
use
rrna
sequenc
northern
ireland
show
chang
bacteri
commun
bronchiectasi
airway
may
fact
driver
exacerb
howev
trend
toward
lower
microbi
divers
describ
term
rel
abund
haemophilu
spp
domin
pseudomona
spp
stabl
patient
postantibiot
treatment
mild
increas
anaerob
bacteria
seen
correspond
decreas
aerob
contrast
howev
rrna
dataset
assess
stabl
exacerb
state
found
p
aeruginosa
commonest
organ
categori
recent
studi
also
uk
reaffirm
import
origin
observ
chang
stabl
exacerb
state
involv
simpl
alter
bronchiectasi
airway
bacteriom
may
earli
specul
specif
pattern
microb
associ
exacerb
data
support
hypothesi
observ
pyrosequenc
uk
dataset
invers
relationship
exist
airway
abund
p
aeruginosa
h
influenza
bronchiectasi
airway
specif
microbi
pattern
associ
exacerb
state
sequenc
approach
also
interestingli
shown
longterm
erythromycin
treatment
advers
affect
h
influenzaedomin
patient
increas
rel
abund
p
aeruginosa
vari
rate
colonis
p
aeruginosa
describ
across
vari
ethnic
group
us
hispan
american
highest
rate
follow
european
american
african
american
recent
data
us
bronchiectasi
research
registri
n
howev
ntm
found
frequent
mac
follow
abscessu
chelona
commonest
isol
ntm
speci
p
aeruginosa
describ
onethird
aureu
oneeighth
patient
colonis
either
speci
less
patient
affect
ntm
patient
detect
ntm
also
develop
bronchiectasi
later
predominantli
femal
studi
europ
found
similar
discord
ntm
bacteria
bronchiectasi
airway
note
howev
ascertain
bia
us
bronchiectasi
research
registri
mani
tertiari
referr
centr
ntm
referr
pattern
potenti
skew
report
data
like
us
howev
ntmassoci
diseas
overal
comparison
geograph
region
howev
current
avail
dataset
permit
us
definit
establish
asia
similar
pattern
ethnic
han
popul
shandong
provinc
eastern
china
southern
chines
citi
guangzhou
observ
predomin
p
aeruginosa
h
influenza
colonis
rate
former
stabl
across
differ
bronchiectasi
aetiolog
identifi
popul
ntm
rate
unlik
us
low
chines
studi
prospect
work
thailand
found
similar
pattern
describ
china
although
popul
klebsiella
pneumonia
detect
equal
proport
h
influenza
south
korea
differ
distribut
high
ntm
similar
us
lower
rate
p
aeruginosa
like
thai
patient
south
korean
also
signific
preval
k
pneumonia
geograph
close
work
japan
howev
report
p
aeruginosa
predomin
airway
bacteria
close
follow
moder
level
ntm
interestingli
pacif
region
specif
central
southern
australia
report
rate
h
influenza
compar
p
aeruginosa
higher
low
occurr
ntm
higher
mean
rel
abund
haemophilu
spp
compar
pseudomona
spp
report
australian
studi
author
propos
bacteriom
base
patient
stratif
system
predict
exacerb
bronchiectasi
system
patient
airway
bacteriom
domin
p
aeruginosa
veillonella
spp
experi
higher
rate
futur
exacerb
compar
patient
whose
airway
domin
h
influenza
addit
h
influenza
domin
individu
experi
milder
diseas
contrast
p
aeruginosa
may
attribut
competit
exclus
organ
interest
observ
importantli
deriv
dataset
bless
trial
assess
patient
histori
least
two
exacerb
per
year
therefor
identifi
pattern
base
comparison
frequent
less
frequent
exacerb
lack
assess
nonexacerb
cultur
base
detect
airway
bacteria
routin
use
bronchiectasi
nextgener
sequenc
ng
approach
use
research
faster
robust
altern
identifi
airway
pathogen
cultureindepend
sequenc
methodolog
appli
bronchiectasi
identifi
greater
degre
airway
microbi
divers
tabl
method
yet
appropri
clinic
use
challeng
bioinformat
analysi
standardis
effici
computeris
come
year
facilit
clinic
translat
spite
increas
explor
bacteriom
use
technolog
advanc
explor
viral
fungal
resid
lung
associ
bronchiectasi
lag
behind
small
number
avail
studi
limit
understand
viral
fungal
contribut
bronchiectasi
geograph
variabl
nonetheless
review
current
understood
respect
contribut
evid
support
clinic
associ
bronchiectasi
current
understand
virom
bronchiectasi
limit
studi
virus
bronchiectasi
rare
assess
compar
baselin
presenc
virus
healthi
individu
recent
work
howev
suggest
role
virus
exacerb
bronchiectasi
bacteri
densiti
divers
remain
stabl
exacerb
earli
work
us
canada
first
report
viral
infect
specif
influenza
b
adenoviru
bronchiectasi
respect
recent
work
china
guangzhou
report
coronaviru
rhinoviru
influenza
b
detect
exacerb
associ
concomit
increas
airway
system
inflamm
system
airway
also
elev
viru
posit
exacerb
interest
work
australian
indigen
children
similarli
illustr
increas
viral
detect
particularli
rhinovirus
exacerb
children
posit
viru
exacerb
also
like
hospitalis
data
howev
elucid
whether
virus
caus
consequ
exacerb
area
futur
investig
despit
recent
work
europ
asiapacif
indic
potenti
role
human
tlymphotrop
viru
type
mediat
inflamm
causat
bronchiectasi
separ
new
zealand
base
studi
similarli
propos
adenoviru
infect
potenti
caus
postinfecti
bronchiectasi
fig
knowledg
pulmonari
mycobiom
less
well
characteris
although
technic
challeng
may
provid
new
insight
potenti
role
bronchiectasi
fungi
separ
kingdom
organ
million
estim
speci
requir
dedic
studi
bronchiectasi
anatom
distort
airway
predispos
patient
acquisit
colonis
fungi
belong
ascomycota
phyla
eg
aspergillu
spp
form
spore
inhal
daili
basi
thousand
fungal
spore
access
airway
depend
underli
state
host
immun
diseas
result
manifest
rang
allerg
immun
hyperreact
invas
sever
immunodefici
diseas
variat
best
characteris
aspergillusassoci
syndrom
outlin
fig
allerg
bronchopulmonari
aspergillosi
abpa
recognis
aetiolog
factor
occurr
bronchiectasi
sensitis
increas
incid
bronchiectasi
asthmat
addit
aspergillu
candida
spp
repres
anoth
fungal
genu
potenti
import
one
routin
cultur
airway
sampl
importantli
candida
spp
abund
oral
caviti
even
healthi
individu
henc
whether
repres
genuin
respiratori
colonis
andor
pathogen
bronchiectasi
remain
uncertain
great
pauciti
data
exist
specif
assess
fungi
airway
patient
bronchiectasi
studi
bronchiectasi
specif
includ
dedic
fungal
cultur
publish
report
base
incident
detect
document
recent
publish
research
prioriti
bronchiectasi
embarc
collabor
work
address
fungi
necessari
import
bronchiectasi
spanish
studi
report
aspergillu
candida
spp
togeth
contribut
highest
proport
fungi
isol
cultur
bronchiectasi
airway
within
aspergillu
genu
fumigatu
common
colonis
filament
fungi
penicillium
scedosporium
fusarium
less
frequent
seen
critic
chronic
antibiot
use
work
associ
prolong
colonis
fungi
data
us
bronchiectasi
research
registri
n
report
incid
aspergillu
spp
popul
two
separ
studi
uk
illustr
fumigatu
colonis
andor
sensitis
posit
correl
ntm
occurr
coexist
chronic
pulmonari
aspergillosi
ntm
infect
predict
mortal
bronchiectasi
culturebas
identif
part
routin
diagnost
microbiolog
work
bronchiectasi
ineffici
fungal
detect
fungal
speci
grow
common
laboratori
media
overcom
work
employ
nextgener
sequenc
ng
target
amplicon
sequenc
wholegenom
shotgun
metagenom
may
reveal
true
divers
fungal
microorgan
within
microbiom
may
colonis
contribut
pulmonari
patholog
bronchiectasi
focu
futur
work
figur
summaris
microbiom
bronchiectasi
consist
bacteriom
virom
mycobiom
base
countri
predomin
organ
identifi
geograph
differ
outlin
europ
us
asiapacif
find
relat
adult
paediatr
popul
also
indic
studi
assess
clinic
phenotyp
bronchiectasi
lack
extens
studi
date
includ
patient
across
five
databas
europ
identifi
four
distinct
phenotyp
sever
pseudomona
infect
chronic
infect
daili
sputum
product
without
colonis
dri
bronchiectasi
contrast
singl
report
asian
analysi
china
patient
assess
four
differ
group
identifi
common
sever
group
postinfect
bronchiectasi
presenc
airway
pseudomona
key
group
chines
studi
includ
mild
idiopath
diseas
young
patient
sever
idiopath
diseas
lateonset
moder
diseas
elderli
third
studi
focus
sole
spanish
nation
databas
patient
identifi
presenc
airway
pseudomona
separ
clinic
phenotyp
set
characteris
sever
diseas
chronic
infect
airflow
obstruct
sever
exacerb
elderli
men
geograph
variat
bronchiectasi
phenotyp
like
relev
understand
diseas
pathogenesi
accord
region
requir
detail
studi
importantli
result
variou
cluster
studi
bronchiectasi
may
repres
true
geograph
variat
diseas
limit
qualiti
quantiti
data
put
cluster
process
larg
remain
uncontrol
referr
bia
overwhelm
messag
across
three
studi
clinic
data
alon
poor
identifi
meaning
patient
cluster
provid
strong
argument
altern
approach
includ
use
omic
patient
stratif
perhap
target
therapeut
approach
futur
applic
specif
region
popul
may
becom
relev
start
deciph
driver
vari
endotyp
diseas
incid
preval
rate
bronchiectasi
continu
increas
global
age
longer
consid
orphan
respiratori
diseas
despit
document
econom
burden
effect
qualiti
life
social
implic
bronchiectasi
rel
neglect
pulmonari
diseas
invest
research
requir
focus
ethnic
variat
account
geograph
differ
permit
personalis
approach
diagnosi
manag
understand
prognosi
across
countri
recommend
research
prioriti
bronchiectasi
european
multicentr
bronchiectasi
audit
research
collabor
embarc
stress
import
larg
cohort
studi
better
understand
vari
aetiolog
drive
diseas
across
differ
popul
elucid
differ
less
studi
organ
includ
fungi
virus
also
highlight
research
focu
key
area
would
improv
understand
diseas
permit
personalis
therapeut
approach
perhap
vari
geograph
region
differ
aetiolog
epidemiolog
microbiolog
bronchiectasi
observ
across
countri
contin
may
influenc
observ
clinic
phenotyp
turn
like
influenc
treatment
outcom
studi
target
geograph
region
pauciti
data
exist
includ
asia
africa
south
america
necessari
effect
treatment
approach
realis
bronchiectasi
condit
licenc
therapi
current
exist
success
like
depend
target
approach
acknowledg
mark
geograph
variabl
associ
heterogen
diseas
